A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care

Journal of Affective Disorders

Volumn 38, Issue 2-3, 1996, Pages 97-111

  Forder, Julien ^a   Kavanagh, Shane ^b   Fenyo, Andrew ^b  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Cost; Economics; Primary care; Selective serotonin re uptake inhibitor; Tricyclic antidepressant

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; CLOMIPRAMINE; DOSULEPIN; DOXEPIN; IMIPRAMINE; LOFEPRAMINE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ADULT; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029973691     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(95)00098-4     Document Type: Article

References (39)

1. Allen, C. and Beecham, J. (1993) Costing services: ideals and reality. In Netten, A. and Beecham, J. (Eds.) Costing Community Care: Theory and Practice, Chapter 3, Ashgate, Aldershot.
2. Beecham, J. (1994) Costing services: an update, Discussion Paper 844, Personal Social Services Research Unit, University of Kent, Canterbury.
3. Birch, S. and Gafni, A. (1994) Cost-effectiveness ratios: in a league of their own, Health Policy 28, 133-141.
4. Broadhead, W.E., Blazer, D.G., George, L.K. and Tse, C.K. (1990) Depression, disability days and days lost from work in a prospective epidemiological study, J. Am. Med. Ass. 264, 2524-2528.
5. Central Statistical Office (1993) Family Expenditure Survey, HMSO, London.
6. Challis, D. and Davies, B. (1986) Case Management in Community Care, Gower, Aldershot.
7. Department of Health (1994) Guidelines for the economic evaluation of pharmaceuticals, press release 94/251, Department of Health, London.
8. Donoghue, J.M. (1994) The prescribing of anti-depressants in general practice: the use of PACT data, Postgrad. Med. J. 70 Suppl. 2, 23-24.
9. Dunbar, G.C., Cohn, J.B. Fabre, L.F. et al. (1991) A comparison of paroxetine, imipramine and placebo in depressed outpatients, Br. J. Psychiatry 159, 394-398.
10. Fadden, G.B., Bebbington, P.E. and Kuipers, L. (1987) The burden of care: the impact of functional psychiatric illness on the patients family, Br. J. Psychiatry 150, 285-292.
11. Freeling, P.R. and Tylee, A. (1992) Depression in general practice. In Paykel, E.S. (Ed.), Handbook of Affective Disorders, Chapter 41, Churchill Livingstone, Edinburgh.
12. Goldberg, D. and Huxley, P. (1980) Mental Illness in the Community: The Pathway to Psychiatric Care, Tavistock, London.
13. Gujarati, D. (1988) Introductory Econometrics, McGraw-Hill, London.
14. Hatziandreu, E.J., Brown, R.E., Revicki, D.A., Turner, R., Martindale, J.J., Levine, S. and Siegel, J.E. (1994) Cost-utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin, Pharmacoeconomics, 5, 249-264.
15. Jenkins, R. (1985) Minor psychiatric morbidity in employed young men and women and its contribution to sickness absence, Br. J. Indust. Med. 42, 147-154.
16. Johnson, D.A.W. (1981) Depression: treatment compliance in general practice, Acta Psychiatr. Scand. 63, Suppl. 290, 447-453.
17. Jönsson, B. and Bebbington, P.E. (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment, Br. J. Psychiatry 164, 665-673.
18. Kavanagh, S. and Knapp, M.R.J. (1995) Mental health care in the UK: evaluating the reforms, Health Affairs, 260-268.
19. Kind, P. and Sorensen, J. (1993) The costs of depression, Int. Clin. Psychopharmacol. 7, 191-195.
20. Knapp, M.R.J. (1995) Costs and outcomes: variations and comparisons. In Knapp, M.R J. (Ed.) The Economic Evaluation of Mental Health Care, Chapter 4, Arena, Aldershot.
21. Knapp, M., Beecham, J. and Allen, C. (1989) The methodology for costing community and hospital services used by clients in the Care in the Community Demonstration programme. Discussion Paper 647, Personal Social Services Research Unit, University of Kent at Canterbury.
22. Knapp, M.R.J., Cambridge., P., Thomason, C., Beecham, J.K., Allen, C. and Darton, R.A. (1992) Care in the Community: Challenge and Demonstration, Ashgate, Aldershot.
23. Meltzer, H., Gill, B., Petticrew, M. and Hinds, K. (1995) OPCS Surveys of Psychiatric Morbidity in Great Britain, Report 1: The Prevalence of Psychiatric Morbidity among Adults Living in Private Households, HMSO, London.
24. MIMS (1994) Monthly Index of Medical Specialties, Haymarket Medical, London.
25. Montgomery, S.A., Henry, J., McDonald, G., Dinan, T., Lader, M., Hindmarch, I., Clare, A. and Nutt, D. (1994) Selective serotonin reuptake inhibitors: meta-analyses of discontinuation rates, Int. Clin. Psychopharmacol. 9, 47-53.
26. Netten, A. (1991) An Economic Approach to the study of social care of elderly people: A perspective on Informal Care. Paper to the European Conference on Informal Care, University of York.
27. Netten, A. (1994) Unit Costs of Community Care, Personal Social Services Research Unit, University of Kent, Canterbury.
28. Netten, A. and Beecham, J., (Eds.) (1993) Costing Community Care: Theory and Practice, Ashgate, Aldershot.
29. Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health and Social Security (1986) Morbidity Statistics from General Practice: Third National Study, HMSO, London.
30. Song, F., Freemantle, N., Sheldon, T., House, A., Watson, P., Long, A. and Mason, J. (1993) Selective serotonin reuptake inhibitors: meta analysis of efficacy and acceptability, Br. Med. J. 306, 683-687.
31. Stewart, A. (1994) Anti-depressant pharmacotherapy: cost comparison of SSRIs and TCAs, Br. J. Med. Econ. 7, 67-79.
32. Thompson, C. (1994) Management of depression in real-life settings: knowledge gained from large-scale clinical trials, Intern. Clin. Psychopharmacol. 9, Suppl. 3, 21-25.
33. Thompson, C. and Thompson, C.M. (1989) The prescription of antidepressants in general practice: a critical review, Hum. Psychopharmacol. 4, 91-102.
34. Thornton, J.G., Lilford, R.J. and Johnson, N. (1992) Decision analysis in medicine, Br. Med. J. 304, 1099-1103.
35. Torrance, G.W. (1986) Measurement of health state utilities for economic appraisal: a review, J. Health Econ. 5, 1-30.
36. Weinstein, M.C. and Stason, W.B. (1977) Foundations of the cost-effectiveness analysis for health and medical practices, New Engl. J. Med. 296, 716-721.
37. Wells, K.B., Stewart, A., Hays, R.D., Burnam, A., Rogers, W., Daniels, M., Berry, S., Greenfield, S. and Ware, J. (1989) The functioning and well-being of depressed patients: results from the Medical Outcomes Study, J. Am. Med. Ass. 262, 914-919.
38. West, R. (1992) Depression, Studies of Current Health Problems No. 105, Office of Health Economics, London.
39. World Health Organisation (1977) Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death: Vol. 1, World Health Organisation, Geneva.